The Illusory Case for Treatment of an Invented Disease

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Feb 4

PMID 35116001

Authors

David J Handelsman

Affiliations

Soon will be listed here.

Citing Articles

Circulating adrenal and gonadal steroid hormones heterogeneity in active young males and the contribution of 11-oxy androgens.

Swart A, van Rooyen D, du Toit T, Heyns B, Molphy J, Wilson M Sci Rep. 2024; 14(1):16226.

PMID: 39003307 PMC: 11246537. DOI: 10.1038/s41598-024-66749-9.

Hormones and Aging: An Endocrine Society Scientific Statement.

Cappola A, Auchus R, Fuleihan G, Handelsman D, Kalyani R, McClung M J Clin Endocrinol Metab. 2023; 108(8):1835-1874.

PMID: 37326526 PMC: 11491666. DOI: 10.1210/clinem/dgad225.

Long vs Short Acting Testosterone Treatments: A Look at the Risks.

Gurayah A, Dullea A, Weber A, Masterson J, Khodamoradi K, Mohamed A Urology. 2022; 172:5-12.

PMID: 36455678 PMC: 9925408. DOI: 10.1016/j.urology.2022.11.016.

References

Jannini E, Screponi E, Carosa E, Pepe M, Giudice F, Trimarchi F . Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl. 2000; 22(6):385-92. DOI: 10.1046/j.1365-2605.1999.00196.x. View

Jasuja G, Bhasin S, Reisman J, Hanlon J, Miller D, Morreale A . Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study. J Gen Intern Med. 2016; 32(3):304-311. PMC: 5331013. DOI: 10.1007/s11606-016-3940-7. View

Jasuja G, Bhasin S, Rose A . Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes. 2017; 24(3):240-245. DOI: 10.1097/MED.0000000000000336. View

Cunningham G, Stephens-Shields A, Rosen R, Wang C, Bhasin S, Matsumoto A . Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab. 2016; 101(8):3096-104. PMC: 4971331. DOI: 10.1210/jc.2016-1645. View

Langouche L, Jacobs A, Van den Berghe G . Nonthyroidal Illness Syndrome Across the Ages. J Endocr Soc. 2019; 3(12):2313-2325. PMC: 6853682. DOI: 10.1210/js.2019-00325. View

Jasuja G, Bhasin S, Reisman J, Berlowitz D, Rose A . Ascertainment of Testosterone Prescribing Practices in the VA. Med Care. 2015; 53(9):746-52. DOI: 10.1097/MLR.0000000000000398. View

Santi D, Granata A, Guidi A, Pignatti E, Trenti T, Roli L . Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial. Eur J Endocrinol. 2016; 174(4):513-22. DOI: 10.1530/EJE-15-1100. View

Donatucci C, Cui Z, Fang Y, Muram D . Long-term treatment patterns of testosterone replacement medications. J Sex Med. 2014; 11(8):2092-9. DOI: 10.1111/jsm.12608. View

Cussons A, Bhagat C, Fletcher S, Walsh J . Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment. Med J Aust. 2002; 177(11-12):678-9. DOI: 10.5694/j.1326-5377.2002.tb05014.x. View

10.

Pappa T, Vagenakis A, Alevizaki M . The nonthyroidal illness syndrome in the non-critically ill patient. Eur J Clin Invest. 2010; 41(2):212-20. DOI: 10.1111/j.1365-2362.2010.02395.x. View

11.

Handelsman D . Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013; 199(8):548-51. DOI: 10.5694/mja13.10111. View

12.

Budoff M, Ellenberg S, Lewis C, Mohler 3rd E, Wenger N, Bhasin S . Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. JAMA. 2017; 317(7):708-716. PMC: 5465430. DOI: 10.1001/jama.2016.21043. View

13.

Roy C, Snyder P, Stephens-Shields A, Artz A, Bhasin S, Cohen H . Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern Med. 2017; 177(4):480-490. PMC: 5433757. DOI: 10.1001/jamainternmed.2016.9540. View

14.

Finkle W, Greenland S, Ridgeway G, Adams J, Frasco M, Cook M . Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One. 2014; 9(1):e85805. PMC: 3905977. DOI: 10.1371/journal.pone.0085805. View

15.

Adler S, Wartofsky L . The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am. 2007; 36(3):657-72, vi. DOI: 10.1016/j.ecl.2007.04.007. View

16.

De Groot L . Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006; 22(1):57-86, vi. DOI: 10.1016/j.ccc.2005.10.001. View

17.

Saad F . The emancipation of testosterone from niche hormone to multi-system player. Asian J Androl. 2014; 17(1):58-60. PMC: 4291879. DOI: 10.4103/1008-682X.137684. View

18.

Taylor B, Wilt T, Fink H, Lambert L, Marshall L, Hoffman A . Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006; 68(4):804-9. DOI: 10.1016/j.urology.2006.04.019. View

19.

Albert S, Morley J . Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review. Clin Endocrinol (Oxf). 2016; 85(3):436-43. DOI: 10.1111/cen.13084. View

20.

Orwoll E, Lambert L, Marshall L, Phipps K, Blank J, Barrett-Connor E . Testosterone and estradiol among older men. J Clin Endocrinol Metab. 2005; 91(4):1336-44. DOI: 10.1210/jc.2005-1830. View